Last reviewed · How we verify
NCT06591169
Lifestyle Changes in PCOS with OSA and NAFLD
NA trial testing diet restriction and exercise in PCOS in 40 participants. Currently enrolling.
1 December 2024
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 5 July 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 15 December 2024 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- diet restriction and exercise
- diet restriction
Conditions studied
Sponsor
Cairo University
Who can join
Adults 30 to 40, female only, with PCOS or NAFLD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of lifestyle changes on liver enzymes, triglycerides, sex hormones, and daytime sleepiness in polycystic ovarian syndrome women with obstructive sleep apnea and fatty liver - a randomized controlled trial.
Ali Ismail AM, Mousa NMA, Elgendy SKM, Al-Emrany AM, et al · · 2025 · cited 3× · PMID 40777876 · DOI 10.5114/pm.2025.152991
Verify or expand the search:
- PubMed search for NCT06591169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for PCOS
Currently open trials in the same condition.
- NCT06424860 — Fish Oil, Metformin and Heart Health in PCOS · Phase 1 · recruiting
- NCT06742710 — Liraglutide Treatment in Obese Infertile PCOS Women · Phase 4 · recruiting
- NCT07255911 — Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS · NA · recruiting
- NCT06793072 — Adipokines in Polycystic Ovary Syndrome · recruiting
- NCT06889454 — Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06591169 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06591169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing